Michael Castellano - BlackRock Science Independent Trustee
BST Etf | USD 37.08 0.34 0.93% |
Mr. Michael J. Castellano is Independent Blackrock Science And Technology Trust . The Board benefits from Mr. Castellanos career in accounting which spans over forty years
Age | 75 |
Tenure | 10 years |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Similar Fund Executives
Showing other executives | One Year Return | ||
Jay Fife | BlackRock Health Sciences | 51 | |
Michael Holland | Reaves Utility If | 75 | |
Rakesh Jain | Tekla Healthcare Investors | 69 | |
Christopher MBA | Tekla Healthcare Investors | N/A | |
Kyle CFA | BlackRock Health Sciences | N/A | |
Charles Park | BlackRock Health Sciences | 57 | |
Valerie Mosley | Eaton Vance Enhanced | 61 | |
James Kirchner | Eaton Vance Enhanced | 54 | |
Mark Fetting | Eaton Vance Enhanced | 67 | |
George Gorman | Eaton Vance Enhanced | 69 | |
John Maney | Pimco Corporate Income | 62 | |
Helen Peters | Eaton Vance Enhanced | 73 | |
Karen Gilomen | Reaves Utility If | 49 | |
Jeffrey Lee | BlackRock Health Sciences | N/A | |
Lisa Phelan | Cohen Steers Reit | 51 | |
Lindsay Sinclair | BlackRock Utility Infrastructur | N/A | |
Jill Kerschen | Reaves Utility If | 44 | |
Theodore Uhl | Reaves Utility If | 45 | |
Thomas CFA | BlackRock Health Sciences | N/A | |
William Reardon | Tekla Healthcare Investors | 74 | |
Albert Laskaj | Cohen And Steers | 43 |
BlackRock Science Tech Money Managers
Henry Gabbay, Independent Trustee | ||
Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Cynthia Egan, Independent Trustee | ||
Jay Fife, Treasurer | ||
R Hubbard, Independent Trustee | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Neal Andrews, Chief Financial Officer | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 33.68 M | ||||
Shares Owned By Insiders | 0.01 % | ||||
Shares Owned By Institutions | 18.53 % | ||||
Number Of Shares Shorted | 14.74 K | ||||
Price To Earning | 5.78 X | ||||
Short Ratio | 0.09 X | ||||
Earnings Per Share | 5.41 X | ||||
Number Of Employees | 17 | ||||
Market Capitalization | 1 B | ||||
Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.